000 03596nam a22003855i 4500
999 _c11248
_d11248
001 11248
003 DE-He213
005 20210706040345.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180529s2018 gw | s |||| 0|eng d
020 _a9783319791142
024 7 _a10.1007/978-3-319-79114-2
_2doi
040 _aES-MaUEC
_bspa
_dES-MaUEC
050 4 _aRC280.S8
_b G37 2018 EB
245 1 0 _aGastric Cardiac Cancer
_cedited by Qin Huang.
264 1 _aCham, Switzerland
_bSpringer
_c2018
300 _a1 recurso en línea (XIII, 328 páginas 197 ilustraciones, 189 ilustraciones a color)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aEsophagogastric Junction -- Cardiac Mucosa -- Epidemiology and Risk Factors -- Natural History -- Clinical Molecular Pathology -- Pathology of Early Gastric Cardiac Cancer -- Pathology of Advanced Gastric Cardiac Cancer -- Gastric Lymphoma -- Diagnosis -- Prognosis and Staging -- Endoscopic Resection of Early Gastric Cardiac Carcinoma -- Pathologic Evaluation of Endoscopic Resection Specimens -- Surgical Therapy -- Chemical Therapy -- Radiotherapy and Chemoradiotherapy -- Palliative Care.
520 3 _aThis book is designed to present readers with comprehensive, high-quality research results on almost all aspects of this carcinoma in clinical management, from correct determination of the esophagogastric junction, issues on cardiac mucosa, epidemiology, and natural history, to clinical, endoscopic, and histopathologic features and diagnostic pitfalls of this carcinoma at both early and advanced stages. Once diagnosed and correctly staged, clinical management of this carcinoma at the early stage is addressed primarily with endoscopic therapy employing the latest endoscopic technology such as endoscopic submucosal dissection, in which detailed technical topics of the endoscopic therapy are written by experts in the field with sections from pre-resection staging and patient preparation to post-resection complications and management. Subsequently, clinical management of gastric cardiac carcinoma at advanced stages is discussed at length with a personalized, multidiscipline approach with strategies from surgical resections with various methods, to pre-, peri- and post-resection chemoradiation therapies as well as the most advanced immunotherapy. A state-of-art approach with the results of meta-analyses and large-scale randomized double-blinded clinical trials are employed throughout these chapters. For patients at the terminal ill stage, the appropriate palliative care plan is presented by experienced clinicians armed with the latest clinical practice guidelines to better manage and help those patients in the last period of their lives.
650 7 _aPatología
_2embne
_9138489
650 7 _aOncología
_9139207
700 1 _aHuang, Qin.
_eeditor literario
_0http://id.loc.gov/authorities/names/n83134359
_0http://viaf.org/viaf/84032986
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319791135
776 0 8 _iEdición impresa:
_z9783319791159
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-79114-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db